AbstractPurpose: To study AMD drusenoid deposits “L”, their density, structure, volume characteristics by morphology‐structural software, their evolution, mostly to atrophy, and lipidomic profile of AMD Atrophy complication to enhance correlations‐links in between.Methods: 154 eyes of 84 patients with AMD drusenoid deposits “L”, Lipid Type(soft Drusen, Drusenoid PED “L”).Deposits were evaluated by OCT(Spectralis HRA‐OCT),Morphology‐Structural software(M‐S software)to let drusenoid deposit contents analyse, grading (volume, contours), measurements: density, structure, volume. 30 AMD Atrophy complication patients' Lipidomic Study: Blood tests, all lipids qualitative, quantitative analysis: neutral lipid by GC, fatty acid too but after BF3 methanol derivation, phospholipids by LC–MS directly, as sphingolipids but firstly hydrolysed, polyinsatured fatty acids metabolites by preparation before LC–MS.Results: AMD Drusenoid Deposits “L” characteristics: OCT/OCT en Face: dark grey, optical empty, fatty, equal and the same in all cross‐section; M‐S software: Density: Low, decreasing during evolution, Structure: increasing during evolution, bell‐shaped curve with increase curve peak; Volume: quite disappearing; so mostly evolution to Atrophy. Atrophy complication Lipidomics profile: medium level Free Cholesterol, low Oxysterols, low Phospholipids(Phosphatidyl Cholines), low total neutral lipids(MUFA/PUFA), high Sphingosins. AMD Drusenoid Deposits “L” characterization (OCT), contents knowledge (M‐S software),evolution mostly to Atrophy(OCT, M‐S Software),AMD Atrophy complication Lipidomics Profile let enhance correlations between lipid quality drusenoid contents and lipid metabolism, so better physiopathology understanding, therapeutic perspectives.Conclusions: Enhancing links‐correlations between aspect, Morphology‐Structural characteristics, evolution of Drusenoid deposits “L” and Lipidomics profile of Atrophy complication let AMD physiopathology, etiopathogenesis understanding, hypothesis formulations, therapeutics perspectives.References.1. Gonzalez C. Age macular degeneration: relevance and interest of lipidomic study for screening, follow‐up and etiopathogeny of AMD. ARVO 2016.
Read full abstract